Received Dec 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | — | — |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | — | — |
was supposed to receive her third dose of the RECOMBIVAX HB vaccine on 10/07/2025. HCP stated that the patient did not receive her third dose; No additional AE; This spontaneous report was received from a medical assistant and referred to a 56 -year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, patient started was with the first and second dose of Hepatitis B Vaccine (Recombinant) Suspension for injection (RECOMBIVAX HB) for prophylaxis (dose, injection site, route of administration, lot number and expiration date were not reported). On 07-Oct-2025, the patient was supposed to receive her third dose of Hepatitis B Vaccine (Recombinant) Suspension for injection (RECOMBIVAX HB), but she did not receive it (inappropriate schedule of product administration). No additional adverse event was reported. Lot # is being requested and will be submitted if received.